Mu, L.-M.; Liu, L.; Liu, R.; Du, Y.-F.; Luo, Q.; Xu, J.-R.; Xie, Y.; Lu, W.-L.
Nanostructured SL9-CpG Lipovaccines Elicit Immune Response for the Treatment of Melanoma. Int. J. Mol. Sci. 2019, 20, 2207.
https://doi.org/10.3390/ijms20092207
AMA Style
Mu L-M, Liu L, Liu R, Du Y-F, Luo Q, Xu J-R, Xie Y, Lu W-L.
Nanostructured SL9-CpG Lipovaccines Elicit Immune Response for the Treatment of Melanoma. International Journal of Molecular Sciences. 2019; 20(9):2207.
https://doi.org/10.3390/ijms20092207
Chicago/Turabian Style
Mu, Li-Min, Lei Liu, Rui Liu, Ya-Fei Du, Qian Luo, Jia-Rui Xu, Ying Xie, and Wan-Liang Lu.
2019. "Nanostructured SL9-CpG Lipovaccines Elicit Immune Response for the Treatment of Melanoma" International Journal of Molecular Sciences 20, no. 9: 2207.
https://doi.org/10.3390/ijms20092207
APA Style
Mu, L. -M., Liu, L., Liu, R., Du, Y. -F., Luo, Q., Xu, J. -R., Xie, Y., & Lu, W. -L.
(2019). Nanostructured SL9-CpG Lipovaccines Elicit Immune Response for the Treatment of Melanoma. International Journal of Molecular Sciences, 20(9), 2207.
https://doi.org/10.3390/ijms20092207